| Metastatic renal carcinoma: Evaluation of antiangiogenic therapy with dynamic ... - UroToday |
|
|
UroTodayIn two phase-III trials involving 51 patients with metastatic renal cell carcinoma (38 men, 13 women; age range, 30-80 years) receiving antiangiogenic drugs ... read more |